Access
To read this story in full you will need to login or make a payment (see right).
Commentary
Nature Medicine 13, 299 - 303 (2007)
doi:10.1038/nm0307-299
Changing funding patterns in tuberculosis
Stefan H E Kaufmann1 & Shreemanta K Parida1
- The authors are at the Max Planck Institute for Infection Biology, Department of Immunology, Charitéplatz 1, 10117 Berlin, Germany. e-mail: kaufmann@mpiib-berlin.mpg.de
Exactly 125 years after the discovery of the etiological agent of tuberculosis (TB), the disease remains as threatening as ever. The insufficient control measures in place today were developed in the late nineteenth and early twentieth centuries.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Research highlightsNature Medicine News and Views (01 Mar 2007)
Research highlightsNature Medicine News and Views (01 Mar 2007)
